Ruiz-Calderón A J, Carrasco F, Duro R, Constantino M
Servicio de Hematología, Hospital Universitario Virgen Macarena, Sevilla.
Sangre (Barc). 1993 Oct;38(5):403-5.
In the present report we describe a 66 year-old-woman, diagnosed of rheumatoid arthritis, who suffered a severe haemorrhagic syndrome caused by the presence of a circulating inhibitor to factor VIII. Inhibitor quantitation was measured with Bethesda test. After treatment with corticosteroids and high-dose immunoglobulin, a good clinical response was obtained; factor VIII:C activity increased with the disappearance of detectable inhibitor. This response was observed more effectively and rapidly than with prednisone treatment alone.
在本报告中,我们描述了一名66岁的女性,被诊断为类风湿性关节炎,她因存在针对凝血因子VIII的循环抑制物而患上严重出血综合征。通过贝塞斯达试验测定抑制物定量。在使用皮质类固醇和大剂量免疫球蛋白治疗后,获得了良好的临床反应;随着可检测到的抑制物消失,凝血因子VIII:C活性增加。与单独使用泼尼松治疗相比,这种反应观察起来更有效、更迅速。